Encompass Health Corp Stock Performance
| EHC Stock | USD 99.96 2.86 2.95% |
Encompass Health has a performance score of 6 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.71, which means possible diversification benefits within a given portfolio. As returns on the market increase, Encompass Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Encompass Health is expected to be smaller as well. Encompass Health Corp right now shows a risk of 1.39%. Please confirm Encompass Health Corp coefficient of variation, total risk alpha, skewness, as well as the relationship between the information ratio and maximum drawdown , to decide if Encompass Health Corp will be following its price patterns.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Encompass Health Corp are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile technical indicators, Encompass Health may actually be approaching a critical reversion point that can send shares even higher in April 2025. ...more
Actual Historical Performance (%)
One Day Return (2.08) | Five Day Return (0.52) | Year To Date Return 5.72 | Ten Year Return 165.3 | All Time Return 2.2 K |
Forward Dividend Yield 0.007 | Payout Ratio | Last Split Factor 1257:1000 | Forward Dividend Rate 0.68 | Dividend Date 2025-04-15 |
1 | Disposition of 2446 shares by Andrew Price of Encompass Health at 92.35 subject to Rule 16b-3 | 12/31/2024 |
| Encompass Health dividend paid on 15th of January 2025 | 01/15/2025 |
2 | Acquisition by Christie Edward M Iii of 292 shares of Encompass Health at 94.4 subject to Rule 16b-3 | 01/16/2025 |
3 | Encompass Health Named One of Fortunes Worlds Most Admired Companies for Fifth Consecutive Year | 02/05/2025 |
4 | Encompass Health Declares Quarterly Dividend of US0.17 Per Share | 02/21/2025 |
5 | Disposition of 410 shares by Andrew Price of Encompass Health at 100.63 subject to Rule 16b-3 | 02/25/2025 |
6 | Disposition of 304 shares by Andrew Price of Encompass Health at 100.14 subject to Rule 16b-3 | 02/28/2025 |
7 | Encompass Health Full Year 2024 Earnings EPS Beats Expectations | 03/04/2025 |
8 | Acquisition by Mark Tarr of 33086 shares of Encompass Health at 98.45 subject to Rule 16b-3 | 03/05/2025 |
9 | Disposition of 416 shares by John Darby of Encompass Health at 100.14 subject to Rule 16b-3 | 03/06/2025 |
10 | Heres How Much You Would Have Made Owning Encompass Health Stock In The Last 15 Years | 03/10/2025 |
11 | Why Encompass Health is a Top Value Stock for the Long-Term | 03/14/2025 |
12 | Thrivent Financial for Lutherans Purchases 128,331 Shares of Encompass Health Co. | 03/19/2025 |
13 | Encompass Health Corp Opens New Rehabilitation Hospital in Athens, Georgia | 03/21/2025 |
| Begin Period Cash Flow | 104.2 M |
Encompass |
Encompass Health Relative Risk vs. Return Landscape
If you would invest 9,400 in Encompass Health Corp on December 24, 2024 and sell it today you would earn a total of 596.00 from holding Encompass Health Corp or generate 6.34% return on investment over 90 days. Encompass Health Corp is generating 0.1104% of daily returns assuming volatility of 1.3913% on return distribution over 90 days investment horizon. In other words, 12% of stocks are less volatile than Encompass, and above 98% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Encompass Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Encompass Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Encompass Health Corp, and traders can use it to determine the average amount a Encompass Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0793
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | EHC | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.39 actual daily | 12 88% of assets are more volatile |
Expected Return
| 0.11 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Encompass Health is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Encompass Health by adding it to a well-diversified portfolio.
Encompass Health Fundamentals Growth
Encompass Stock prices reflect investors' perceptions of the future prospects and financial health of Encompass Health, and Encompass Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Encompass Stock performance.
| Return On Equity | 0.23 | ||||
| Return On Asset | 0.0865 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 12.41 B | ||||
| Shares Outstanding | 100.71 M | ||||
| Price To Earning | 18.73 X | ||||
| Price To Book | 4.73 X | ||||
| Price To Sales | 1.82 X | ||||
| Revenue | 5.37 B | ||||
| Gross Profit | 2.23 B | ||||
| EBITDA | 1.19 B | ||||
| Net Income | 599.4 M | ||||
| Cash And Equivalents | 21.8 M | ||||
| Cash Per Share | 0.60 X | ||||
| Total Debt | 354.6 M | ||||
| Debt To Equity | 1.69 % | ||||
| Current Ratio | 1.21 X | ||||
| Book Value Per Share | 20.51 X | ||||
| Cash Flow From Operations | (3.1 M) | ||||
| Earnings Per Share | 4.49 X | ||||
| Market Capitalization | 9.78 B | ||||
| Total Asset | 6.53 B | ||||
| Retained Earnings | 796.7 M | ||||
| Working Capital | 45.9 M | ||||
| Current Asset | 659.58 M | ||||
| Current Liabilities | 474.74 M | ||||
About Encompass Health Performance
By analyzing Encompass Health's fundamental ratios, stakeholders can gain valuable insights into Encompass Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Encompass Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Encompass Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 51.36 | 48.80 | |
| Return On Tangible Assets | 0.09 | 0.05 | |
| Return On Capital Employed | 0.11 | 0.11 | |
| Return On Assets | 0.07 | 0.07 | |
| Return On Equity | 0.22 | 0.23 |
Things to note about Encompass Health Corp performance evaluation
Checking the ongoing alerts about Encompass Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Encompass Health Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Encompass Health Corp has about 21.8 M in cash with (3.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.6. | |
| Encompass Health has a poor financial position based on the latest SEC disclosures | |
| Over 98.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from gurufocus.com: Encompass Health Corp Opens New Rehabilitation Hospital in Athens, Georgia |
- Analyzing Encompass Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Encompass Health's stock is overvalued or undervalued compared to its peers.
- Examining Encompass Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Encompass Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Encompass Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Encompass Health's stock. These opinions can provide insight into Encompass Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Encompass Stock analysis
When running Encompass Health's price analysis, check to measure Encompass Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Encompass Health is operating at the current time. Most of Encompass Health's value examination focuses on studying past and present price action to predict the probability of Encompass Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Encompass Health's price. Additionally, you may evaluate how the addition of Encompass Health to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |